R1 RCM (RCM) Lowered to Hold at BidaskClub
R1 RCM (NASDAQ:RCM) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
RCM has been the topic of several other reports. Zacks Investment Research raised R1 RCM from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Robert W. Baird reissued a “hold” rating and issued a $5.00 target price on shares of R1 RCM in a research report on Tuesday, September 26th.
R1 RCM (RCM) opened at $4.28 on Friday. R1 RCM has a 12-month low of $2.02 and a 12-month high of $4.64. The stock has a market capitalization of $449.40, a price-to-earnings ratio of -16.46 and a beta of -0.48.
A number of institutional investors and hedge funds have recently made changes to their positions in RCM. Vanguard Group Inc. acquired a new stake in R1 RCM during the 2nd quarter worth about $10,550,000. State Street Corp acquired a new stake in R1 RCM during the 2nd quarter worth about $5,327,000. Paradigm Capital Management Inc. NY grew its position in R1 RCM by 14.8% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 6,967,900 shares of the financial services provider’s stock worth $25,851,000 after purchasing an additional 900,753 shares during the period. Unterberg Capital LLC acquired a new stake in R1 RCM during the 3rd quarter worth about $2,579,000. Finally, Northern Trust Corp grew its position in R1 RCM by 46.4% during the 2nd quarter. Northern Trust Corp now owns 1,145,411 shares of the financial services provider’s stock worth $4,295,000 after purchasing an additional 362,773 shares during the period. 47.41% of the stock is currently owned by institutional investors.
R1 RCM Company Profile
R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.